Powered by

Emalex Biosciences Appoints Dr. Atul R. Mahableshwarkar as Senior Vice President of Drug Development

Aug 06, 2019 - Business Wire
Board and Executive Moves

Emalex Biosciences Inc., a biopharmaceutical company developing innovative therapies for patients with neurological and psychiatric conditions, today announced the appointment of Atul Mahableshwarkar, MD, as Senior Vice President of Drug Development. In this capacity, Dr. Mahableshwarkar will provide leadership to the Clinical Affairs, Pharmacovigilance, Regulatory Affairs and Quality Assurance divisions at Emalex.

This press release features multimedia. View the full release here: https:/...